TY  - JOUR
AU  - Cejalvo, María J
AU  - Legarda, Mario
AU  - Abella, Eugenia
AU  - Cabezudo, Elena
AU  - Encinas, Cristina
AU  - García-Feria, Ana
AU  - Gironella, Mercedes
AU  - Iñigo, Belén
AU  - Martín, Jesús
AU  - Ribas, Paz
AU  - Ruíz, Mª Ángeles
AU  - González, Yolanda
AU  - Vicuña, Isabel
AU  - Ramírez, Ángel
AU  - Fernández, Pascual
AU  - de la Rubia, Javier
PY  - 2019
DO  - 10.1111/bjh.16286
UR  - http://hdl.handle.net/10668/14782
T2  - British journal of haematology
LA  - en
KW  - daratumumab
KW  - dialysis
KW  - multiple myeloma
KW  - relapse
KW  - Aged
KW  - Antibodies, Monoclonal
KW  - Disease-Free Survival
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Multiple Myeloma
KW  - Recurrence
KW  - Renal Dialysis
KW  - Retrospective Studies
KW  - Survival Rate
TI  - Single-agent daratumumab in patients with relapsed and refractory multiple myeloma requiring dialysis: results of a Spanish retrospective, multicentre study.
TY  - research article
VL  - 190
ER  -